Table of Content

1 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years

2 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer

3 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Forces
3.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment

4 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market - By Geography
4.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Value and Market Share by Regions
4.1.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Value ($) by Region (2015-2020)
4.1.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Value Market Share by Regions (2015-2020)
4.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Production and Market Share by Major Countries
4.2.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production by Major Countries (2015-2020)
4.2.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production Market Share by Major Countries (2015-2020)
4.3 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Consumption and Market Share by Regions
4.3.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by Regions (2015-2020)
4.3.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Share by Regions (2015-2020)

5 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market - By Trade Statistics
5.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Export and Import
5.2 United States Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Export and Import (2015-2020)
5.3 Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Export and Import (2015-2020)
5.4 China Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Export and Import (2015-2020)
5.5 Japan Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Export and Import (2015-2020)
5.6 India Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Export and Import (2015-2020)
5.7 ...

6 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market - By Type
6.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production and Market Share by Types (2015-2020)
6.1.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production by Types (2015-2020)
6.1.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production Market Share by Types (2015-2020)
6.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Value and Market Share by Types (2015-2020)
6.2.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Value by Types (2015-2020)
6.2.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Value Market Share by Types (2015-2020)
6.3 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Price and Growth Rate of Preface (2015-2020)
6.4 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Price and Growth Rate of Eluxadoline (2015-2020)
6.5 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Price and Growth Rate of Alosetron (2015-2020)
6.6 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Price and Growth Rate of Rifaximin (2015-2020)
6.7 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Price and Growth Rate of Loperamide (2015-2020)
6.8 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Price and Growth Rate of Diphenoxylate + Atropine (2015-2020)
6.9 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Production, Price and Growth Rate of Dicyclomine and Hyoscyamine (2015-2020)

7 Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market - By Application
7.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption by Applications (2015-2020)
7.1.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption Market Share by Applications (2015-2020)
7.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption and Growth Rate of Hospitals (2015-2020)
7.3 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption and Growth Rate of Clinics (2015-2020)
7.4 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Consumption and Growth Rate of Others (2015-2020)

8 North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market
8.1 North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
8.2 United States Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
8.3 Canada Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
8.4 Mexico Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
8.5 The Influence of COVID-19 on North America Market

9 Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Analysis
9.1 Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
9.2 Germany Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
9.3 United Kingdom Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
9.4 France Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
9.5 Italy Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
9.6 Spain Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
9.7 The Influence of COVID-19 on Europe Market

10 Asia-Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Analysis
10.1 Asia-Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
10.2 China Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
10.3 Japan Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
10.4 South Korea Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
10.5 Southeast Asia Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
10.6 India Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market

11 Middle East and Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Analysis
11.1 Middle East and Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
11.2 Saudi Arabia Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
11.3 UAE Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
11.4 South Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market

12 South America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Analysis
12.1 South America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
12.2 Brazil Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Size
12.3 The Influence of COVID-19 on South America Market

13 Company Profiles
13.1 Salix Pharmaceuticals Ltd
13.1.1 Salix Pharmaceuticals Ltd Basic Information
13.1.2 Salix Pharmaceuticals Ltd Product Profiles, Application and Specification
13.1.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Performance (2015-2020)
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Basic Information
13.2.2 GlaxoSmithKline Product Profiles, Application and Specification
13.2.3 GlaxoSmithKline Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Performance (2015-2020)
13.3 Pfizer
13.3.1 Pfizer Basic Information
13.3.2 Pfizer Product Profiles, Application and Specification
13.3.3 Pfizer Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Performance (2015-2020)
13.4 Astellas Pharmaceuticals
13.4.1 Astellas Pharmaceuticals Basic Information
13.4.2 Astellas Pharmaceuticals Product Profiles, Application and Specification
13.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Performance (2015-2020)
13.5 Actavis
13.5.1 Actavis Basic Information
13.5.2 Actavis Product Profiles, Application and Specification
13.5.3 Actavis Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Performance (2015-2020)
13.6 AstraZenenca
13.6.1 AstraZenenca Basic Information
13.6.2 AstraZenenca Product Profiles, Application and Specification
13.6.3 AstraZenenca Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Performance (2015-2020)

14 Market Forecast - By Regions
14.1 North America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Forecast (2020-2025)
14.2 Europe Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Forecast (2020-2025)
14.3 Asia-Pacific Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Forecast (2020-2025)
14.4 Middle East and Africa Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Forecast (2020-2025)
14.5 South America Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Forecast (2020-2025)

15 Market Forecast - By Type and Applications
15.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Forecast by Types (2020-2025)
15.1.1 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs Market Forecast by Applications (2020-2025)